HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis
- PMID: 38255953
- PMCID: PMC10815612
- DOI: 10.3390/ijms25020882
HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis
Abstract
Studies concerning the genetic background of IgA vasculitis (IgAV), a small-vessel vasculitis occurring predominantly in childhood, have confirmed that the HLA-DRB1 gene showed a strong association with disease susceptibility. The objective was to investigate human leukocyte antigen (HLA) polymorphisms among Croatian patients with IgAV and their influence on disease susceptibility and clinical heterogeneity. Thus, 130 children with IgAV and 202 unrelated healthy individuals were enrolled in the study. Genomic DNA was extracted from whole peripheral blood, and HLA-A, -B, -DRB1 and -DQB1 gene polymorphism analysis was performed. HLA-A*03 (21.4% vs. 12.38%, p = 0.0092), HLA-B*37 (2.9% vs. 0.2%, p = 0.0054) and HLA-DRB1*12 (3.1% vs. 0.7%, p = 0.0216) alleles were significantly more frequent in IgAV patients than in controls. High-resolution typing revealed significantly higher frequency of HLA-DRB1*10:01 and -DRB1*11:03 among IgAV patients with gastrointestinal manifestations of the disease in comparison to controls (p = 0.0021 and p = 0.0301, respectively), while HLA-DRB1*14:01P occurred significantly more often in the group of patients who developed nephritis during the course of the disease (17.5% vs. 4.5%, p = 0.0006). Our results demonstrated that there is an association of HLA-A*03, HLA-B*37 and HLA-DRB1*12 alleles with susceptibility to IgAV in the examined Croatian pediatric population. Studies which aim to determine the HLA profile may contribute to the elucidation of the genetic background of autoimmune diseases, including IgAV.
Keywords: Croatians; HLA-DRB1; IgA vasculitis; allele frequencies; high-resolution typing; human leukocyte antigen polymorphisms; next generation sequencing.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Piram M., Maldini C., Biscardi S., De Suremain N., Orzechowski C., Georget E., Regnard D., Koné-Paut I., Mahr A. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: A population-based study. Rheumatology. 2017;56:1358–1366. doi: 10.1093/rheumatology/kex158. - DOI - PubMed
-
- Jelusic M., Sestan M., Giani T., Cimaz R. New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis-is it time to change the paradigm of the most common systemic vasculitis in childhood? Front. Pediatr. 2022;10:853724. doi: 10.3389/fped.2022.853724. - DOI - PMC - PubMed
-
- Ozen S., Pistorio A., Iusan S.M., Bakkaloglu A., Herlin T., Brik R., Buoncompagni A., Lazar C., Bilge I., Uziel Y., et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann. Rheum. Dis. 2010;69:798–806. doi: 10.1136/ard.2009.116657. - DOI - PubMed
-
- Sestan M., Kifer N., Frkovic M., Sapina M., Srsen S., Varga M.B., Ovuka A., Held M., Gracanin A.G., Kozmar A., et al. Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis. Ther. Adv. Musculoskelet. Dis. 2021;13:1759720X211024828. doi: 10.1177/1759720X211024828. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous